In this study, two human oral cancer cell lines (OECM-1 and HSC-3), human dysplastic oral keratinocyte (DOK) representing OPMD cells and normal human oral keratinocytes (HOK), were incubated at 37 °C in a 5% CO2 incubator. The human oral squamous carcinoma cell line OECM-1 (from a Taiwanese betel quid chewer) and HSC-3 tongue squamous carcinoma cell line are well-established models for squamous cell carcinoma [20,21]. OECM-1 and HSC-3 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM). DOK cells were incubated in high glucose DMEM medium supplemented with 10% fetal bovine serum (HyClone, Logan, UT, USA), 2 mM glutamine (HyClone, Logan, UT, USA), 5 µg/mL hydrocortisone (HyClone, Logan, UT, USA), 100 µg/mL streptomycin (HyClone, Logan, UT, USA), and 100 U/mL penicillin–streptomycin (Invitrogen, Carlsbad, CA, USA). Normal HOK cells (ScienCell, Carlsbad, USA) were incubated in oral keratinocyte medium (OKM, Cat. #2611, ScienCell, Carlsbad, USA). The medium of cell culture was refreshed every three days. Detailed information on cell culture has been reported in our previous study [20,21].
We added different concentrations (0, 20, 40, 60, 80, and 100 µM) of arecoline to HOK for 24 h to assess cell viability (Figure S1). We added MTT solution (5 mg/mL) to the cells and incubated them for 2 h at 37 °C in a CO2 incubator. Subsequently, the viable cell percentage compared with vehicle controls was calculated by using an ELISA reader (el800, Bio Tek, Winooski, VT, USA).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.